Skip to main content

and
  1. Article

    Open Access

    Glucose–insulin–potassium therapy in patients with acute coronary syndrome: a meta-analysis of randomized controlled trials

    Glucose-insulin-potassium (GIK) has been advocated in the setting of acute coronary syndrome (ACS) to reduce ischemia-related arrhythmias and myocardial injury. We conducted a meta-analysis of randomized contr...

    Pei-Yin **, Hai-San Zhang, **ao-Yan Guo, Wei-Fang Liang in BMC Cardiovascular Disorders (2014)